Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
4.360
+0.140 (3.32%)
Dec 20, 2024, 4:00 PM EST - Market closed
Eledon Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 260 | 44 | 31 | 63 | 233 | 8 | |
| Market Cap Growth | 206.11% | 38.87% | -50.29% | -72.98% | 3004.22% | -50.11% | |
| Enterprise Value | 183 | -16 | -34 | -31 | 284 | -3 | |
| Last Close Price | 4.36 | 1.80 | 2.28 | 4.41 | 15.40 | 10.44 | |
| PB Ratio | 2.36 | 6.04 | 0.37 | 0.38 | 1.22 | 0.79 | |
| P/TBV Ratio | 2.26 | - | 0.61 | 0.76 | 2.13 | 0.79 | |
| Debt / Equity Ratio | 0.01 | 0.05 | 0.01 | 0.00 | 0.00 | 0.03 | |
| Quick Ratio | 6.26 | 13.12 | 8.71 | 19.28 | 46.04 | 6.84 | |
| Current Ratio | 6.53 | 14.41 | 9.19 | 20.07 | 46.57 | 7.54 | |
| Return on Equity (ROE) | -25.89% | -255.03% | -70.89% | -19.46% | -22.80% | -133.66% | |
| Return on Assets (ROA) | -33.36% | -29.56% | -18.88% | -12.53% | -7.98% | -63.42% | |
| Return on Capital (ROIC) | -41.74% | -58.10% | -19.91% | -12.96% | -8.28% | -73.02% | |
| Earnings Yield | -9.42% | -267.55% | -280.45% | -54.69% | -9.77% | -212.88% | |
| FCF Yield | -14.36% | -90.75% | -90.62% | -45.83% | -6.52% | -184.24% | |
| Buyback Yield / Dilution | -86.63% | -72.34% | 3.61% | -921.03% | -121.41% | -31.03% | |
| Total Shareholder Return | -86.63% | -72.34% | 3.61% | -921.03% | -121.41% | -31.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.